Deka Bank Deutsche Girozentrale Blueprint Medicines Corp Transaction History

Deka Bank Deutsche Girozentrale

$59.4 Billion
Q3 2025

A detailed history of Deka Bank Deutsche Girozentrale transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 25,883 shares of BPMC stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,883

Previous 25,883 -0.0%

Holding current value

$3.35 Million

Previous $3.31 Million 23.11%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$73.17 - $99.79 $53,633 - $73,146	733 Added 2.91%	25,883 $2.53 Million
Q1 2022 Apr 28, 2022	BUY	$54.1 - $110.08 $59,510 - $121,088	1,100 Added 4.57%	25,150 $1.64 Million
Q4 2021 Feb 02, 2022	BUY	$94.25 - $115.99 $56,550 - $69,594	600 Added 2.56%	24,050 $2.58 Million
Q1 2021 Apr 28, 2021	BUY	$90.71 - $108.28 $108,851 - $129,936	1,200 Added 5.39%	23,450 $2.15 Million
Q4 2020 Mar 12, 2021	SELL	$92.08 - $124.48 $791,888 - $1.07 Million	-8,600 Reduced 27.88%	22,250 $2.56 Million

Q3 2020 Oct 29, 2020	BUY	$66.45 - $92.7 $2.05 Million - $2.86 Million	30,850 New	30,850 $2.75 Million
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $108,055 - $184,666	-2,246 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$66.73 - $82.59 $149,875 - $185,497	2,246 New	2,246 $180,000
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $2.5 Million - $3.48 Million	-34,346 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$73.54 - $97.8 $1.33 Million - $1.77 Million	18,066 Added 110.97%	34,346 $3.18 Million
Q1 2019 May 10, 2019	BUY	$48.7 - $86.6 $117,123 - $208,273	2,405 Added 17.33%	16,280 $1.21 Million
Q4 2018 Feb 12, 2019	SELL	$45.57 - $74.26 $109,595 - $178,595	-2,405 Reduced 14.77%	13,875 $702,000
Q3 2018 Nov 09, 2018	SELL	$58.91 - $78.32 $23,564 - $31,327	-400 Reduced 2.4%	16,280 $0
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $59,740 - $99,156	980 Added 6.24%	16,680 $1.02 Million
Q1 2018 May 03, 2018	SELL	$73.28 - $102.95 $21,984 - $30,885	-300 Reduced 1.88%	15,700 $1.37 Million
Q3 2017 Nov 06, 2017	BUY	$42.37 - $69.67 $677,920 - $1.11 Million	16,000	16,000 $726,000

Others Institutions Holding BPMC

# of Institutions

Shares Held

8.58M

Call Options Held

Put Options Held

14.8K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Blueprint Medicines Corp Transaction History